Harbinger Health appoints Ajit Singh as CEO

Singh will lead the company's growth, advancing early cancer detection products using advanced sequencing technologies and artificial intelligence.

Ajit Singh / LinkedIn

Harbinger Health, a biotechnology company advancing early cancer detection, has appointed Indian-origin executive Ajit Singh as chief executive officer (CEO).

Singh, a Harbinger board member since 2024, succeeds Stephen Hahn, who will transition to CEO emeritus and special advisor while remaining on the board.

Also read: Ravi Dankanikote appointed Chief Growth Officer of national security firm

A veteran of the diagnostics industry with leadership experience at Siemens and multiple oncology-focused ventures, Singh joins Harbinger at a pivotal stage as it advances the development of blood-based cancer detection tests.

“Early cancer detection remains one of the most critical, yet unsolved, challenges in oncology. I am excited to lead the team as we strive to make earlier cancer detection a reality, improving outcomes for millions” Singh said.

Prior to joining Harbinger, Singh was a partner at Artiman Ventures, held CEO roles at BioImagene and Siemens Healthcare’s digital radiology division, and taught at Stanford University and Princeton University.

He holds advanced degrees in engineering and computer science from Columbia University, Syracuse University, and Banaras Hindu University, and is an author of two books with five patents.

Harbinger’s technology leverages proprietary methylation patterns in cell-free DNA to detect cancers, particularly those with high incidence and mortality linked to obesity. Recent data showcased the potential of its assays across multiple cancer types, supported by analytical innovations to enhance detection accuracy.

Founded by Flagship Pioneering in 2020, Harbinger Health aims to make early cancer detection a routine, affordable, and transformative part of global healthcare.

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login